Molecular Pathology of Breast Cancer /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Edición: | 1st ed. 2016. |
| Materias: |
Tabla de Contenidos:
- Preface
- Translating Markers in Clinical Practice
- Pre-analytical Variables, Tissue Quality and Clinical Samples from Breast Cancer Patients
- Impact of Analytical Variables in Breast Cancer Biomarkers Analysis
- Hormone Receptors in Breast Cancer
- Human Epidermal Growth Factor Receptor 2 (HER2)
- Triple Negative Breast Cancer
- Proliferation Markers in Breast Cancer
- Novel IHC Based Biomarkers in Breast Cancer.-Tumor Heterogeneity in Breast Cancer
- Breast Cancer Stem Cells
- The Tumor Microenvironmen t as a Metastasis Biomarker in Breast Cancer
- Tumor Infiltrating Lymphocytes as a prognostic and predictive biomarker in breast cancer
- Novel Imaging Based Biomarkers in Breast Cancer
- Circulating Tumor Markers for Breast Cancer Managgement
- Circulating Tumor Cells
- Circulating Nucleic acids (RNA/DNA)in Breast Cancer
- Prognostic Factors for Ductal Carcinoma in Situ of the Breast
- Prognostic and Predictive Gene Expression Signatures in Breast Cancer
- Genomic Markers ER-negative Breast Cancer
- Next-Generation Seguencing Basxed Testing for Breast Cancer
- Epigenetic Mechanism in Breast Cancer
- Nocoding RNAs in Breast Cancer
- Alternative Splicing in Breast Cancer
- Pharmagocenomics of Breast Cancer
- Applied Proteomics in Breast Cancer
- Biomarkers in the Clinic
- Index.